Trnĕný, M., Verhoef, G., Dyer, M. J., Ben Yehuda, D., Patti, C., Canales, M., Lopez, A., Awan, F. T., Montgomery, P. G., Janikova, A., Barbui, A. M., Sulek, K., Terol, M. J., Radford, J., Guidetti, A., Di Nicola, M., Siraudin, L., Hatteville, L., Schwab, S., Oprea, C. and Gianni, A. M. (2018) “A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy”, Haematologica. Pavia, Italy, 103(8), pp. 1351-1358. doi: 10.3324/haematol.2017.168401.